[Leukemic meningo-encephalopathy. Clinical and therapeutic considerations].
D000208:Acute Disease; D001215:Asparaginase / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003036:Cobalt Isotopes / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use*; D006801:Humans; D007945:Leukemia, Lymphoid / Q000134:cerebrospinal fluid / Q000150:complications* / Q000188:drug therapy; D008590:Meningoencephalitis / Q000188:drug therapy / Q000209:etiology*; D008727:Methotrexate / Q000627:therapeutic use* / Q000633:toxicity; D011867:Radioisotope Teletherapy
D003036:Cobalt Isotopes; D003561:Cytarabine; D001215:Asparaginase; D008727:Methotrexate
La meningo-encefalopatia leucemica. Considerazioni cliniche e terapeutiche